Shukra Medtech Stock Price Analysis and Quick Research Report. Is Shukra Medtech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Shukra Medtech. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Shukra Medtech has a PE ratio of 83.9184876012767 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Shukra Medtech has ROA of 21.5958% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Shukra Medtech has a Current ratio of 3.6282.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Shukra Medtech has a ROE of 29.9398%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Shukra Medtech has a Debt to Equity ratio of 0.0594 which means that the company has low proportion of debt in its capital.

• Sales growth: Shukra Medtech has reported revenue growth of 74.0129% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Shukra Medtech for the current financial year is 50.7610292367135%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Shukra Medtech is Rs 0.01 and the yield is 0.0146%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Shukra Medtech is Rs 0.8146. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Shukra Medtech in Ticker for free. Also, one can get the intrinsic value of Shukra Medtech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Shukra Medtech FAQs

Q1. What is Shukra Medtech share price today?
Ans: The current share price of Shukra Medtech is Rs 68.36.

Q2. What is the market capitalisation of Shukra Medtech?
Ans: Shukra Medtech has a market capitalisation of Rs 3025.08339984 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Shukra Medtech?
Ans: The PE ratio of Shukra Medtech is 83.9184876012767 and the P/B ratio of Shukra Medtech is 26.081648225868, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Shukra Medtech share?
Ans: The 52-week high share price of Shukra Medtech is Rs 75.4, and the 52-week low share price of Shukra Medtech is Rs 40.06.

Q5. Does Shukra Medtech pay dividends?
Ans: Currently, Shukra Medtech pays dividends. Dividend yield of Shukra Medtech is around 0.0146%.

Q6. What are the face value and book value of Shukra Medtech shares?
Ans: The face value of Shukra Medtech shares is Rs 1, while the book value per share of Shukra Medtech is around Rs 2.621. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Shukra Medtech?
Ans: Shukra Medtech has a total debt of Rs 5.0195 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Shukra Medtech?
Ans: The ROE of Shukra Medtech is 29.9398% and ROCE of Shukra Medtech is 36.9775%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Shukra Medtech a good buy for the long term?
Ans: The Shukra Medtech long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Shukra Medtech undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Shukra Medtech appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Shukra Medtech’s financials?
Ans: You can review Shukra Medtech’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.